abstract |
The present invention relates to N- {4- [3-chloro-4- (3-fluoro-benzyloxy) phenylamino] -quinazolin-6-yl having characteristic powder X-ray diffraction data as described in the specification. } -Acrylamide p-Toluenesulfonate polymorphs, methods for their preparation, pharmaceutical compositions containing them, and their use. |